Search: Aphria

A Closer Look at Aphria’s Reported Profit

This is a copy of the August 4th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, After months of disappointing developments in the roll-out of cannabis legalization in Canada, Aphria delivered strong revenue in its final quarter of its fiscal 2019, breaking a trend of sequential declines in sales […] READ MORE: https://www.newcannabisventures.com/a-closer-look-at-aphrias-reported-profit/

Aphria Inc. Announces 158% Increase in Adult-Use Sales and Profitable Fourth Quarter

Reports Profitable Fourth QuarterRecord Net Revenue of $128.6 Million, Up 75% from Prior QuarterRevenue for Adult-use Cannabis of $18.5 Million, Up 158% from Prior QuarterProvides Fiscal Year 2020 Outlook LEAMINGTON, ON, Aug. 1, 2019 /CNW/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today reported its results for the fourth quarter and fiscal year ended May 31, 2019.…

Aphria Reports Net Cannabis Revenue of $28.4 Million

Aphria Inc. Announces 158% Increase in Adult-Use Sales and Profitable Fourth Quarter Reports Profitable Fourth Quarter Record Net Revenue of $128.6 Million, Up 75% from Prior Quarter Revenue for Adult-use Cannabis of $18.5 Million, Up 158% from Prior Quarter Provides Fiscal Year 2020 Outlook LEAMINGTON, ON, Aug. 1, 2019 /PRNewswire/ – Aphria Inc. (“Aphria” or […] READ MORE: https://www.newcannabisventures.com/aphria-reports-net-cannabis-revenue-of-28-4-million/

Better buy: Aphria vs. Canopy Growth

If you’re looking to buy a marijuana stock, Aphria (NYSE: APHA) and Canopy Growth(NYSE: CGC) should probably be on your list for consideration. They’re two of the largest Canadian cannabis producers in terms of production capacity. Both Aphria and Canopy Growth are well positioned in the Canadian adult-use recreational marijuana market and in international medical cannabis markets. Canopy Growth has been the bigger winner so…

Aphria adds to planned portfolio of vapes & concentrates with PAX Labs agreement

LEAMINGTON, ON, June 7, 2019 /PRNewswire/ – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA and NYSE: APHA) today announced an agreement with San Francisco-based PAX Labs, Inc. (“PAX“), a leader in the design and development of premium cannabis vaporization devices, that will enable Aphria to provide premium cannabis extracts in pods designed for use with PAX’s innovative Era device and platform. The Company plans to…

PAX Labs Partners With Canadian Licensed Producers Aphria, Aurora, Organigram and Supreme Cannabis

Toronto, CA (June 7, 2019) — PAX Labs, Inc. , a leading consumer technology brand in cannabis, is pleased to announce that Aphria Inc. (” Aphria “) (TSX: APHA)(NYSE: APHA), Aurora Cannabis Inc. (“ Aurora ”) (TSX:ACB)(NYSE:ACB), Organigram Holdings Inc. (“ Organigram ”) (TSX-V: OGI)(NASDAQ: OGI), and The Supreme Cannabis Company, Inc. (“ Supreme Cannabis ”) (TSX: FIRE) have signed on as PAX Era brand partners. PAX designs and develops premium…